Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy.

MLA

Puebla-Osorio, Nahum, et al. “Enhanced Tumor Control and Survival in Preclinical Models with Adoptive Cell Therapy Preceded by Low-Dose Radiotherapy.” Frontiers in Oncology, Oct. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.3389/fonc.2024.1407143.

APA

Puebla-Osorio, N., Fowlkes, N. W., Barsoumian, H. B., Xega, K., Srivastava, G., Kettlun-Leyton, C., Nizzero, S., Voss, T., Riad, T. S., Wong, C., Huang, A., Yun Hu, Mitchell, J., Mingee Kim, Rafiq, Z., Kewen He, Sezen, D., Hsu, E., Masrorpour, F., & Maleki, A. (2024). Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy. Frontiers in Oncology, 1–16. https://doi.org/10.3389/fonc.2024.1407143

Chicago

Puebla-Osorio, Nahum, Natalie Wall Fowlkes, Hampartsoum B. Barsoumian, Kristina Xega, Gitika Srivastava, Claudia Kettlun-Leyton, Sara Nizzero, et al. 2024. “Enhanced Tumor Control and Survival in Preclinical Models with Adoptive Cell Therapy Preceded by Low-Dose Radiotherapy.” Frontiers in Oncology, October, 1–16. doi:10.3389/fonc.2024.1407143.